These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4366126)

  • 1. Estracyt (NSC 89199) as a substrate for phosphatases in human serum.
    Tritsch GL; Shukla SK; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):38-9. PubMed ID: 4366126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with estramustine phosphate in advanced prostatic cancer].
    Klein D
    Wien Med Wochenschr; 1972 Jul; 122(30):458-60. PubMed ID: 4114990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].
    de Leval J; Petit R; Bouffioux C
    Acta Urol Belg; 1974 Jul; 42(3):326-35. PubMed ID: 4440596
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
    Müntzing J; Shukla SK; Chu TM; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):65-8. PubMed ID: 4835492
    [No Abstract]   [Full Text] [Related]  

  • 5. [Substrate specificity and the stability of a phosphoryl phosphatase from rabbit serum].
    Zech R; Zürcher K
    Hoppe Seylers Z Physiol Chem; 1973 May; 354(5):583-6. PubMed ID: 4372150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of prostatic carcinoma with orally administered Estracyt].
    Mayer EJ
    Ther Umsch; 1975 Feb; 32(2):114-9. PubMed ID: 1118820
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of rapidly progressing prostatic carcinoma with estracyt.
    Lindberg B
    J Urol; 1972 Aug; 108(2):303-6. PubMed ID: 5047424
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the antiprostatic action of estracyt, a nitrogen mustard of estradiol.
    Kirdani RY; Müntzing J; Varkarakis MJ; Murphy GP; Sandberg AA
    Cancer Res; 1974 May; 34(5):1031-7. PubMed ID: 4823900
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A; Morvay J; Vécsei B
    Orv Hetil; 1981 Apr; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract]   [Full Text] [Related]  

  • 10. Estracyt in hormone-resistant prostatic carcinoma.
    Szendröi Z; Könyves I; Szendi L; Eckhardt S; Hartay F
    Int Urol Nephrol; 1974; 6(2):101-10. PubMed ID: 4448622
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M; Lutherer S; Terhorst B
    Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alkaline phosphatase content of human leukocytes following marrow suppression by nitrogen mustard.
    TRUBOWITZ S; FELDMAN D; BENANTE C; HUNT VM
    J Lab Clin Med; 1958 Aug; 52(2):259-65. PubMed ID: 13564003
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical application of phosphohydrolase measurements in cancer.
    Schwartz MK; Fleisher M; Bodansky O
    Ann N Y Acad Sci; 1969 Oct; 166(2):775-93. PubMed ID: 4314105
    [No Abstract]   [Full Text] [Related]  

  • 14. [DETERMINATION OF PROSTATIC PHOSPHATASE IN BLOOD SERUM].
    PINHEIRO J
    Hospital (Rio J); 1965 Feb; 67():283-92. PubMed ID: 14329942
    [No Abstract]   [Full Text] [Related]  

  • 15. Discriminative value of serum phosphatases in patients with prostatic carcinoma.
    Lämmel A; Krieg M; Becker H; Braun BE
    Urology; 1988 Oct; 32(4):293-300. PubMed ID: 2845624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-groups and serum lipids and phosphatases.
    Beckman L
    Lancet; 1969 Oct; 2(7624):799. PubMed ID: 4186043
    [No Abstract]   [Full Text] [Related]  

  • 17. [TECHNIQUE FOR THE EVALUATION OF SERUM ACID AND ALKALINE PHOSPHOMONOESTERASES (PHOSPHATASES)].
    RUIZ R; CAMPONOVO PB
    Laboratorio; 1963 Nov; 35():401-6. PubMed ID: 14115929
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent data on the mechanism of action of oestrogens in the treatment of prostatic tumour patients.
    Szendröi Z; Kocsár L; Karika Z; Füzi M; Tarján G; Reischel G; Eckhardt S
    Int Urol Nephrol; 1974; 5(3):311-23. PubMed ID: 4829136
    [No Abstract]   [Full Text] [Related]  

  • 19. [The activity of non-specific phosphatases in the blood of patients with periodontal diseases during healing of periodontal wounds].
    Janczuk Z; Banach J; Gregorczyk J
    Czas Stomatol; 1970 Sep; 23(9):1091-6. PubMed ID: 4318865
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of serum aminotransferases and phosphatases, and prothrombin level after experimental hemorrhage.
    Glowiński S; Worowski K; Farbiszewski R
    Pol Med J; 1972; 11(4):962-7. PubMed ID: 4342778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.